FinsMEs:
ChromaCode, a Carlsbad, CA-based genomics multiplexing platform company developing accessible and affordable solutions for laboratories, patients and physicians, received a strategic investment from corporate venture capital fund Shimadzu Future Innovation Fund L.P., with general partner Global Brain Corporation.
The amount of the deal was not disclosed.
